187 related articles for article (PubMed ID: 19176398)
1. Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
Chauhan SC; Vannatta K; Ebeling MC; Vinayek N; Watanabe A; Pandey KK; Bell MC; Koch MD; Aburatani H; Lio Y; Jaggi M
Cancer Res; 2009 Feb; 69(3):765-74. PubMed ID: 19176398
[TBL] [Abstract][Full Text] [Related]
2. MUC13 mucin augments pancreatic tumorigenesis.
Chauhan SC; Ebeling MC; Maher DM; Koch MD; Watanabe A; Aburatani H; Lio Y; Jaggi M
Mol Cancer Ther; 2012 Jan; 11(1):24-33. PubMed ID: 22027689
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of MUC13 is associated with intestinal-type gastric cancer.
Shimamura T; Ito H; Shibahara J; Watanabe A; Hippo Y; Taniguchi H; Chen Y; Kashima T; Ohtomo T; Tanioka F; Iwanari H; Kodama T; Kazui T; Sugimura H; Fukayama M; Aburatani H
Cancer Sci; 2005 May; 96(5):265-73. PubMed ID: 15904467
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
[TBL] [Abstract][Full Text] [Related]
5. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
[TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y
Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
[TBL] [Abstract][Full Text] [Related]
7. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.
Greenaway J; Moorehead R; Shaw P; Petrik J
Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT.
Scoles DR; Pavelka J; Cass I; Tran H; Baldwin RL; Armstrong K; Karlan BY
Gynecol Oncol; 2007 Jan; 104(1):120-8. PubMed ID: 16956650
[TBL] [Abstract][Full Text] [Related]
10. Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
Hempel N; How T; Dong M; Murphy SK; Fields TA; Blobe GC
Cancer Res; 2007 Jun; 67(11):5231-8. PubMed ID: 17522389
[TBL] [Abstract][Full Text] [Related]
11. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
12. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
[TBL] [Abstract][Full Text] [Related]
13. Mucin gene expression in ovarian cancers.
Giuntoli RL; Rodriguez GC; Whitaker RS; Dodge R; Voynow JA
Cancer Res; 1998 Dec; 58(23):5546-50. PubMed ID: 9850092
[TBL] [Abstract][Full Text] [Related]
14. Reduction of miR‑132‑3p contributes to gastric cancer proliferation by targeting MUC13.
He L; Qu L; Wei L; Chen Y; Suo J
Mol Med Rep; 2017 May; 15(5):3055-3061. PubMed ID: 28339011
[TBL] [Abstract][Full Text] [Related]
15. The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
Wang R; Yu C; Zhao D; Wu M; Yang Z
Oncol Rep; 2013 Aug; 30(2):667-76. PubMed ID: 23708057
[TBL] [Abstract][Full Text] [Related]
16. The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas.
Walsh MD; Young JP; Leggett BA; Williams SH; Jass JR; McGuckin MA
Hum Pathol; 2007 Jun; 38(6):883-92. PubMed ID: 17360025
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.
Sung HY; Park AK; Ju W; Ahn JH
Yonsei Med J; 2014 Sep; 55(5):1206-13. PubMed ID: 25048476
[TBL] [Abstract][Full Text] [Related]
18. Increased expression and aberrant localization of mucin 13 in metastatic colon cancer.
Gupta BK; Maher DM; Ebeling MC; Sundram V; Koch MD; Lynch DW; Bohlmeyer T; Watanabe A; Aburatani H; Puumala SE; Jaggi M; Chauhan SC
J Histochem Cytochem; 2012 Nov; 60(11):822-31. PubMed ID: 22914648
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition.
Baba T; Kariya M; Higuchi T; Mandai M; Matsumura N; Kondoh E; Miyanishi M; Fukuhara K; Takakura K; Fujii S
Gynecol Oncol; 2007 Jun; 105(3):703-11. PubMed ID: 17376520
[TBL] [Abstract][Full Text] [Related]
20. Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.
Gulmann C; Sheehan KM; Conroy RM; Wulfkuhle JD; Espina V; Mullarkey MJ; Kay EW; Liotta LA; Petricoin EF
J Pathol; 2009 Aug; 218(4):514-9. PubMed ID: 19396842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
